News
Better survival with S-1 plus docetaxel in stage III gastric cancer
Postoperative adjuvant S-1 plus docetaxel significantly improved survival over S-1 alone.
News
Gut microbiome may predict nivolumab efficacy in gastric cancer
The diversity of the gut microbiome could potentially predict nivolumab response.
News
CRC risk in young adults: Not as high as previously reported
Previous studies of colorectal cancer included carcinoid tumors as well as colorectal adenocarcinoma, which has inflated estimates of risk,...
News
CRC risk in young adults: Not as high as previously reported
Previous studies of colorectal cancer included carcinoid tumors as well as colorectal adenocarcinoma, which has inflated estimates of risk,...
News
COVID-19 vaccines: Safe for immunocompromised patients?
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
Patients with cancer a ‘high priority’ for COVID-19 vaccine, says AACR task force
“We conclude that patients with an active cancer should be considered for priority access to COVID-19 vaccination.”
News
Margetuximab approved for HER2-positive metastatic breast cancer
The monoclonal antibody margetuximab-cmkb demonstrated superiority over trastuzumab.
News
COVID-19 vaccines: Safe for immunocompromised patients?
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
Pembrolizumab ‘preferred choice’ in MSI-H/dMMR metastatic CRC
Compared with chemotherapy, pembrolizumab doubled progression-free survival and improved the overall response rate in this patient population.